# CHAARTED (NCT00309985)

> Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT00309985
- Phase: PHASE3
- Status: COMPLETED
- Sponsor: ECOG-ACRIN Cancer Research Group
- Conditions: Metastatic Hormone-sensitive Prostate Cancer
- Interventions: androgen-deprivation therapy; docetaxel
- Enrollment: 790
- Primary outcome: Overall Survival

## Commentary we found

- X threads: 95
- YouTube: 67
- Podcasts: 53

## Order

Deep, $1,950, price fixed at order: https://www.erudio.com/contact?report=chaarted-nct00309985

## Free build

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT00309985", "email": "<work email>"}; the inbox owner confirms by the emailed link.